Positioning “Time-in-Range” in the Treatment of Diabetes in India

Abstract

Recent increases in the usage of continuous glucose monitoring technology have provided people living with diabetes and health‑care professionals with access to a variety of novel glucose control indicators. Some of these indicators are valuable for research, while others are useful clinically. Time-in-range (TIR) is a metric that denotes the proportion of time per day that a person’s glucose level is within a specified goal range. There is evidence relating TIR to risk of complications and it is becoming an excepted endpoint in clinical trials. There is an inverse relationship between TIR and glycated hemoglobin. In addition, the duration and severity of time below range and time above range are also discussed. This paper summarizes recent guidelines regarding the “TIR” goals for different individuals with different types of diabetes. As is always the case, glycemic objectives should be tailored to the individual. Finally, this article discusses the tool of TIR’s positioning in India and the specific populations/patient profiles that will benefit from the intervention